Barclays’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.33M Buy
411,531
+124,161
+43% +$1M ﹤0.01% 1888
2025
Q1
$2.41M Sell
287,370
-65,124
-18% -$546K ﹤0.01% 1903
2024
Q4
$2.79M Buy
352,494
+56,110
+19% +$444K ﹤0.01% 2003
2024
Q3
$2.47M Buy
296,384
+169,756
+134% +$1.41M ﹤0.01% 2027
2024
Q2
$804K Sell
126,628
-30,749
-20% -$195K ﹤0.01% 2245
2024
Q1
$953K Sell
157,377
-74,643
-32% -$452K ﹤0.01% 2439
2023
Q4
$1.41M Buy
232,020
+175,852
+313% +$1.07M ﹤0.01% 2386
2023
Q3
$236K Sell
56,168
-2,979
-5% -$12.5K ﹤0.01% 2951
2023
Q2
$183K Sell
59,147
-27,846
-32% -$86.2K ﹤0.01% 3129
2023
Q1
$120K Buy
86,993
+24,451
+39% +$33.7K ﹤0.01% 3434
2022
Q4
$124K Buy
62,542
+23,286
+59% +$46.2K ﹤0.01% 3350
2022
Q3
$79K Sell
39,256
-25,429
-39% -$51.2K ﹤0.01% 3501
2022
Q2
$205K Sell
64,685
-1,060
-2% -$3.36K ﹤0.01% 3107
2022
Q1
$273K Sell
65,745
-119,278
-64% -$495K ﹤0.01% 3140
2021
Q4
$886K Buy
185,023
+118,790
+179% +$569K ﹤0.01% 2267
2021
Q3
$354K Buy
66,233
+41,778
+171% +$223K ﹤0.01% 2746
2021
Q2
$124K Sell
24,455
-94,713
-79% -$480K ﹤0.01% 3066
2021
Q1
$802K Buy
119,168
+13,049
+12% +$87.8K ﹤0.01% 2416
2020
Q4
$485K Sell
106,119
-24,620
-19% -$113K ﹤0.01% 2333
2020
Q3
$508K Sell
130,739
-13,719
-9% -$53.3K ﹤0.01% 2303
2020
Q2
$688K Buy
144,458
+20,482
+17% +$97.5K ﹤0.01% 2140
2020
Q1
$431K Sell
123,976
-16,168
-12% -$56.2K ﹤0.01% 2191
2019
Q4
$676K Buy
140,144
+72,051
+106% +$348K ﹤0.01% 2520
2019
Q3
$198K Sell
68,093
-201,546
-75% -$586K ﹤0.01% 3062
2019
Q2
$1.93M Buy
269,639
+211,562
+364% +$1.52M ﹤0.01% 1837
2019
Q1
$823K Buy
58,077
+56,751
+4,280% +$804K ﹤0.01% 2291
2018
Q4
$18K Sell
1,326
-41,625
-97% -$565K ﹤0.01% 3405
2018
Q3
$953K Sell
42,951
-325,205
-88% -$7.22M ﹤0.01% 2282
2018
Q2
$6.04M Buy
+368,156
New +$6.04M 0.01% 923